Thromboembolism and mechanical heart valves: A randomized study revisited

Annals of Thoracic Surgery

Volumn 66, Issue 1, 1998, Pages 101-107

  Kuntze, Carl E E ^a   Blackstone, Eugene H ^a   Ebels, Tjark ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; DIPYRIDAMOLE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM;

ANTICOAGULANTS; AORTIC VALVE; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MITRAL VALVE; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; THROMBOEMBOLISM;

EID: 0032126637     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00313-0     Document Type: Article

References (30)

1. 1. Kuntze CEE, Ebels T, Eygelaar A, Homan van der Heide JN. Rates of thromboembolism with three different mechanical heart valve prostheses: randomized study. Lancet 1989;I:514-7.
2. 2. Kuntze CEE, Ebels T, Eijgelaar A, Homan van der Heide JN. Long-term evaluation of mechanical heart valves. Lancet 1989;I:1020-1.
3. 3. Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet 1959;2:754-8.
4. 4. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-7.
5. 5. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-5.
6. 6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
7. 7. Blackstone EH, Naftel DC, Turner ME. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-24.
8. 8. Blackstone EH. Methods and limitations of follow up assessment (clinical studies of time-related events). In: Bodnar E, Frater RWM, eds. Replacement cardiac valves. New York: Pergamon Press, 1991:391-434.
9. 9. Blackstone EH, Kirklin JW. Death and other time related events after valve replacement. Circulation 1985;72:753-67.
10. 10. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
11. 11. Blackstone EH. Analysis of thrombosis, thromboembolism and bleeding after heart valve replacement as time-related outcome events. In: Butchart EG, Bodnar E, eds. Current issues in heart valve disease, thrombosis embolism and bleeding. London: ICR Publishers, 1992.
12. 12. Baskerville JC, Toogood JH. Guided regression modeling for prediction and exploration of structure with many explanatory variables. Technometrics 1982;24:9-17.
13. 13. Bloomfield P, Kitchin AH, Wheatley DJ, Walbaum PR, Lutz W, Miller HC. A prospective evaluation of the Björk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation 1986;73:1213-22.
14. 14. Antunes MJ. Clinical performance of St. Jude and Medtronic-Hall prostheses: a randomized comparative study. Ann Thorac Surg 1990;50:743-7.
15. 15. Vogt S, Hoffmann J, Roth J, et al. Heart valve replacement with the Björk-Shiley and St. Jude Medical prostheses: a randomized comparison in 178 patients. Eur Heart J 1990;11:583-91.
16. 16. Beaudet RL, Poirier NL, Doyle D, Nakhl G, Gauvin C. The Medtronic-Hall cardiac valve: 71/2 years' experience. Ann Thorac Surg 1986;42:644-50.
17. 17. Akins CW. Long-term results with the Medtronic-Hall valvular prosthesis. Ann Thorac Surg 1996;61:806-13.
18. 18. Jamieson WRE, Pelletier LC, Pomar JL. Clinical performance of the Duromedics bileaflet pyrolite mechanical prosthesis. Can J Surg 1992;35:605-11.
19. 19. Klepetko W, Moritz A, Khünl-Brady G, et al. Implantation of the Duromedics bileaflet cardiac valve prosthesis in 400 patients. Ann Thorac Surg 1987;44:303-9.
20. 20. Daenen W, Van Kerrebroeck C, Stalpaert G, et al. The Björk-Shiley Monostrut valve. J Thorac Cardiovasc Surg 1993;106:918-27.
21. 21. Nakano S, Kawashima Y, Matsuda H, et al. A five-year appraisal and hemodynamic evaluation of the Björk-Shiley Monostrut valve. J Thorac Cardiovasc Surg 1991;101:881-7.
22. 22. Alvarez L, Escudero C, Figuera D, Castillo-Olivares L. The Björk-Shiley valve prosthesis, analysis of long-term evolution. J Thorac Cardiovasc Surg 1992;104:1249-58.
23. 23. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;86:635-41.
24. 24. Mitchell RS, Miller DC, Stinson EB, et al. Significant patient-related determinants of prosthetic valve performance. J Thorac Cardiovasc Surg 1986;91:807-17.
25. 25. Akins CW. Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 1995;60:1836-44.
26. 26. Aris A, Igual A, Padro JM, et al. The Spanish Monostrut study group: a ten-year experience with 8,599 implants. Ann Thorac Surg 1996;62:40-7.
27. 27. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM. Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors: recommendations for the Medtronic-Hall valve. Circulation 1991;84(suppl 3):61-9.
28. 28. Butchart EG. The significance of sudden death and unwitnessed death after heart valve replacement. J Heart Valve Dis 1994;3:1-4.
29. 29. Rooney SJ, Moreno de la Santa P, Lewis PA, Butchart EG. Sudden death in a large prosthetic valve series based on a single prosthesis: experience with the Medtronic-Hall valve. J Heart Valve Dis 1994;3:5-9.
30. 30. Antunes MJ, Wessels A, Sadowski RG, et al. Medtronic Hall valve replacement in a third-world population group. J Thorac Cardiovasc Surg 1988;95:980-93.